Pro Medicus (PME) AGM 2025 summary

Opening remarks and agenda

• Welcomed shareholders to a hybrid AGM in Melbourne, acknowledged traditional land owners, and introduced board members and key executives.

• Outlined meeting procedures for questions and voting, both in-person and online.

• Celebrated another highly successful year, attributing achievements to technology, management, and staff dedication.

• Highlighted the company's robust business model and ongoing commitment to service excellence.

Financial performance review

• Achieved record FY2025 revenue of AUD 213 million (up 31.9%) and net profit after tax of AUD 115.2 million (up 39.2%).

• Underlying EBIT reached AUD 157.7 million, up 40.5%, with a 74% EBIT margin.

• Cash and liquid investments rose to AUD 210.7 million after share buybacks and increased dividends, with the company remaining debt free.

• Results to date in FY2026 are ahead of budget, with strong momentum expected in the second half due to major contract implementations.

Board and executive committee updates

• Board and management confident of achieving all goals in the current three-year strategic plan, with new ambitious targets set for FY2027–2029.

• Plans to expand the board to add new skills as the company grows, with a recent increase in the non-executive director fee cap approved.

• Management team, led by Dr. Sam Hupert, recognized for long-term stability and expertise.

• Board continues to invest in staff and management in line with strategic objectives.